Thyrotoxicosis and pregnancy.
D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000188:drug therapy; D007037:Hypothyroidism / Q000150:complications; D007361:Intelligence Tests; D007455:Iodine / Q000008:administration & dosage; D008431:Maternal-Fetal Exchange; D008713:Methimazole / Q000008:administration & dosage / Q000627:therapeutic use; D010348:Patient Care Team; D011247:Pregnancy; D011248:Pregnancy Complications; D011441:Propylthiouracil / Q000008:administration & dosage / Q000627:therapeutic use; D013961:Thyroid Gland / Q000187:drug effects; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D014284:Triiodothyronine / Q000097:blood
D014284:Triiodothyronine; D008713:Methimazole; D011441:Propylthiouracil; D013972:Thyrotropin; D007455:Iodine; D013974:Thyroxine